Cost-effectiveness of Sofosbuvir-based hepatitis C regimens in Central and West Africa (ANRS 12342)

S. Boyer; M. Baudoin; M. Nishimwe; M. E. Woode; G. Maradan; M. Lemoine; B. Sylla; C. Kouanfack; P. Carrieri; N. Rouveau; R. Moh; M. Seydi; A. Attia; K. Lacombe

doi:10.1016/S0168-8278(18)30581-6

Journal articles

Cost-effectiveness of Sofosbuvir-based hepatitis C regimens in Central and West Africa (ANRS 12342)

S. Boyer M. Baudoin M. Nishimwe M. E. Woode G. Maradan M. Lemoine B. Sylla C. Kouanfack P. Carrieri ¹ N. Rouveau R. Moh M. Seydi A. Attia K. Lacombe

1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-02146894
Contributor : Jean-Charles DUFOUR Connect in order to contact the contributor
Submitted on : Tuesday, June 4, 2019 - 11:50:12 AM
Last modification on : Wednesday, November 3, 2021 - 9:44:44 AM

Cost-effectiveness of Sofosbuvir-based hepatitis C regimens in Central and West Africa (ANRS 12342)

Identifiers

Collections

Citation

Export

Metrics

16

Cost-effectiveness of Sofosbuvir-based hepatitis C regimens in Central and West Africa (ANRS 12342)

Identifiers

Collections

Citation

Export

Share

Metrics

16